股票 › MNKD
曼恩凯德制药 MNKD
美股市值排名 #3070
$3.90 +$0.14 (+3.72%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $3.85 -1.28%
开盘$3.92
昨收$3.76
当日区间$3.80 – $4.09
成交量4.99M
市值$1.25B
市盈率（TTM）–
股息率–
财报
财报日平均波动±6.5%近16次财报
收涨次数6 / 1638% 的概率
最佳反应+18.5%
最差反应-13.2%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 5 Aug 2026 | After Market | ±10.3% | -5.12% | 符合区间 |
| 2026/Q1 | 6 May 2026 | After Market | ±16.6% | -0.28% | 符合区间 |
| 2025/Q4 | 26 Feb 2026 | Pre Market | ±13.6% | -7.43% | 符合区间 |
| 2025/Q3 | 5 Nov 2025 | Pre Market | – | +10.58% | – |
| 2025/Q2 | 6 Aug 2025 | Pre Market | ±10.1% | -13.16% | 超出定价预期 |
| 2025/Q1 | 8 May 2025 | Pre Market | – | -4.54% | – |
| 2024/Q4 | 26 Feb 2025 | After Market | ±9.6% | -4.39% | 符合区间 |
| 2024/Q3 | 7 Nov 2024 | After Market | ±10.1% | -0.61% | 符合区间 |
| 2024/Q2 | 7 Aug 2024 | Pre Market | ±14.6% | -4.93% | 符合区间 |
| 2024/Q1 | 8 May 2024 | After Market | ±10.2% | -2.05% | 符合区间 |
| 2023/Q4 | 27 Feb 2024 | After Market | ±14.9% | +3.70% | 符合区间 |
| 2023/Q3 | 7 Nov 2023 | After Market | ±12.8% | -3.95% | 符合区间 |
| 2023/Q2 | 7 Aug 2023 | After Market | ±11.6% | +18.48% | 超出定价预期 |
| 2023/Q1 | 9 May 2023 | After Market | ±9.4% | +15.79% | 超出定价预期 |
| 2022/Q4 | 23 Feb 2023 | After Market | ±9.2% | +3.64% | 符合区间 |
| 2022/Q3 | 8 Nov 2022 | Pre Market | ±9.6% | +4.96% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$109.38M+42.9% YoY
营业利润-$835,000.00-107.8% YoY
净利润-$19.03M-2,949.1% YoY
摊薄每股收益-$0.06
自由现金流-$23.45M-399.4% YoY
经营现金流-$18.37M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率75.4%
营业利润率1.8%
净利率-11.1%
资产收益率-7.6%
流动比率1.72
负债/资产比率109.2%
现金及投资$111.13M
总负债$328.77M
净现金（净负债）-$217.64M
暂无评论——快来第一个聊聊 MNKD。
登录后参与讨论。